Bies RR - Search Results

1

Sex, race, and smoking impact olanzapine exposure.

Bigos KL, Pollock BG, Coley KC, Miller DD, Marder SR, Aravagiri M, Kirshner MA, Schneider LS, Bies RR. Bigos KL, et al. Among authors: bies rr. J Clin Pharmacol. 2008 Feb;48(2):157-65. doi: 10.1177/0091270007310385. J Clin Pharmacol. 2008. PMID: 18199892 Clinical Trial.

2

Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques.

Bies RR, Gastonguay MR, Coley KC, Kroboth PD, Pollock BG. Bies RR, et al. Am J Geriatr Psychiatry. 2002 Nov-Dec;10(6):696-705. Am J Geriatr Psychiatry. 2002. PMID: 12427578 Clinical Trial.

3

Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants.

Bies RR, Bigos KL, Pollock BG. Bies RR, et al. J Gend Specif Med. 2003;6(3):12-20. J Gend Specif Med. 2003. PMID: 14513571 Review.

4

Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.

Nolin TD, Gastonguay MR, Bies RR, Matzke GR, Frye RF. Nolin TD, et al. Among authors: bies rr. Clin Pharmacol Ther. 2003 Dec;74(6):555-68. doi: 10.1016/j.clpt.2003.09.003. Clin Pharmacol Ther. 2003. PMID: 14663458 Clinical Trial.

5

Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.

Lotrich FE, Bies R, Muldoon MF, Manuck SB, Smith GS, Pollock BG. Lotrich FE, et al. Psychopharmacology (Berl). 2005 Mar;178(2-3):268-75. doi: 10.1007/s00213-004-2006-4. Epub 2004 Sep 9. Psychopharmacology (Berl). 2005. PMID: 15365685 Clinical Trial.

6

Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects.

Bies RR, Feng Y, Lotrich FE, Kirshner MA, Roose S, Kupfer DJ, Pollock BG. Bies RR, et al. J Clin Pharmacol. 2004 Dec;44(12):1352-9. doi: 10.1177/0091270004269647. J Clin Pharmacol. 2004. PMID: 15545305 Clinical Trial.

7

Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbances.

Bies RR, Mulsant BH, Rosen J, Huber KA, Wilson NL, Kirshner MA, Pollock BG. Bies RR, et al. Am J Geriatr Pharmacother. 2005 Jun;3(2):87-91. doi: 10.1016/j.amjopharm.2005.07.002. Am J Geriatr Pharmacother. 2005. PMID: 16129385

8

A genetic algorithm-based, hybrid machine learning approach to model selection.

Bies RR, Muldoon MF, Pollock BG, Manuck S, Smith G, Sale ME. Bies RR, et al. J Pharmacokinet Pharmacodyn. 2006 Apr;33(2):195-221. doi: 10.1007/s10928-006-9004-6. Epub 2006 Mar 28. J Pharmacokinet Pharmacodyn. 2006. PMID: 16565924

9

Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.

Feng Y, Pollock BG, Ferrell RE, Kimak MA, Reynolds CF 3rd, Bies RR. Feng Y, et al. Among authors: bies rr. Br J Clin Pharmacol. 2006 May;61(5):558-69. doi: 10.1111/j.1365-2125.2006.02629.x. Br J Clin Pharmacol. 2006. PMID: 16669849 Free PMC article. Clinical Trial.

10

Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies.

Lotrich FE, Bies RR, Smith GS, Pollock BG. Lotrich FE, et al. Among authors: bies rr. J Psychopharmacol. 2006 Jul;20(4 Suppl):33-40. doi: 10.1177/1359786806066044. J Psychopharmacol. 2006. PMID: 16785268 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page